Search

everythinglearnresearchcommunity

for

Search:↓

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Occipital hair follicles in male pattern baldness respond uniquely to testosterone, not androgen-insensitive.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Mutations in certain receptors can cause diseases and offer new treatment options.

Dihydrotestosterone (DHT) and its active metabolites play a key role in various diseases, and the development of 5α-reductase inhibitors can help treat these conditions.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Researchers created a new mouse model, G4, that mimics human PCOS symptoms and links the condition to a specific gene.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Gut bacteria can lower androgen levels in male mice.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Meloside A may help protect hair cells from damage linked to hair loss.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Androgens help motor neurons grow by increasing neuritin.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

Androgens increase cervical cancer risk and affect its development.